True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.
about
Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan AfricaSelf-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysisCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalOutcomes of antiretroviral therapy in Vietnam: results from a national evaluationAre they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban MalawiSurvival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern MalawiAssociation of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan AfricaOutcomes of HIV-positive patients lost to follow-up in African treatment programmesPatient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewOverestimates of survival after HAART: implications for global scale-up effortsMortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe.Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013.What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort studyAdjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programsCorrecting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adultsFour-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators.Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection.Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi.12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008.Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countriesScale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West AfricaAnti-retroviral treatment outcomes among older adults in Zomba district, Malawi.High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort.Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya.Effects of leisure activities and psychosocial support on medication adherence and clinic attendance among children on antiretroviral therapy.Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomesUnderstanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.Predictors of Loss to follow-up in Patients Living with HIV/AIDS after Initiation of Antiretroviral Therapy.
P2860
Q21134515-A80B5F3B-49B8-4AA0-907C-F38540738EB3Q21144651-35331C21-4ED8-4566-B13D-E0B3DFB253EBQ27000197-DE65FBEB-7C78-43F0-A372-6A903AA67E92Q28476337-0283F6DF-A382-4944-B71C-47FC1B15AF8AQ28486180-F0E975B7-DBE9-473A-A7C5-B1590A05F154Q28533819-608B0477-A160-4C2F-A57A-CF090125282AQ28553184-5A13DA34-7CBF-4FF5-A6BB-40B5D567E7CEQ28728715-8C4AFCDA-FD0D-46A1-8E76-05ED9F75F22AQ30238937-2AAF0954-0189-45FF-B125-6CEA3A92CBDBQ33302944-471D54CD-CDF0-43D8-BDB1-E410172561CFQ33322531-6F21ED55-3605-445E-878E-F9E8E0FC3DB6Q33460434-D75514A4-B1D0-4FA9-8789-28A72CF4C7EEQ33537984-D91B4CA9-C132-4AD1-A7F2-43952105BC6BQ33646721-6DFED0F6-D562-452D-8302-16FF6FFDB437Q33714596-0E8E24EB-6348-4577-AC15-303B395ED0C7Q33715786-037B5373-29AA-4E9C-B9B0-51B380F21A42Q33737751-558AD499-D9CE-4E8A-B3AC-49D14500155DQ33770158-320E37FF-ECAB-4298-860F-8264CFA61E6FQ33774697-0F3E806E-767A-4562-BF38-B0EA09867A1EQ33803701-0484B4FC-4356-4F9C-A675-A11BF2EA8803Q33820144-F6124DDB-F8D3-4776-970E-B2F2EDD6B1CCQ33838306-2DE13374-97BC-4CE5-BC31-5FCEBEA9DFF3Q33864631-591DE57A-C288-4675-B333-43DB9A5306ADQ33869315-26C66E0A-DBF7-4CC7-A511-BFB05983479AQ33882803-6AF5D7AC-C72A-412D-9DE1-53BB5A9FDDA3Q33924799-2F1454DE-7930-4876-922E-87FDA68ADA1EQ33943480-63DEEDD1-0EC8-486F-AABB-4C9AE729EB56Q33947235-D70E3C36-CDAC-429C-858D-DBB8B02A39DFQ33965572-CA27CF88-0770-4A6A-8660-D7D96FFD98F6Q33975574-94EDE01E-5381-45F6-8E7B-9C40C5654909Q34015581-09DE171E-BD4D-410F-AEDF-709AB1364B46Q34056735-6DFBB3F5-F300-40DA-AFC6-FAB8923FE3B1Q34059653-8BBC66E9-F090-43BB-99E0-ECBFF91CD20AQ34075017-688E823C-4D1C-4404-96BD-60869B3C116CQ34092713-306C62DA-FF21-4E8F-9BAD-929915F8B965Q34139870-F3F330EB-072B-4346-89D0-4FF995B7634CQ34166980-F88CC484-42CA-4499-8E53-2FBC5FEBDFA3Q34169040-9A628D9F-2A69-46F5-B738-483E1E6BADDFQ34288562-2A76E44A-183C-4638-A5F0-15D9419545F0Q34320356-65F2163F-69CC-4AFC-A0B2-378CED5FDD99
P2860
True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@en
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@nl
type
label
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@en
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@nl
prefLabel
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@en
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@nl
P2093
P2860
P921
P356
P1476
True outcomes for patients on ...... "lost to follow-up" in Malawi.
@en
P2093
Anthony D Harries
Chao-Sung Chang
Erik J Schouten
Joseph Kwong-Leung Yu
Kuo-Yang Wang
Simon D Makombe
P2860
P304
P356
10.2471/BLT.06.037739
P407
P577
2007-07-01T00:00:00Z